January 01, 2016
Australia amended Narcotic Drugs Act to authorize regulated medical cannabis industry.
| Name | Type | Mentions | |
|---|---|---|---|
| Australia | location | 355 | View Entity |
HOUSE_OVERSIGHT_024734.jpg
This document is page 98 of a 'Cannabis Investment Report' dated December 2017 by Ackrell Capital, LLC. It details the legislative and regulatory landscape regarding medical cannabis in various Latin American countries (Colombia, Argentina, Chile, Brazil, Mexico, Peru), the Caribbean (Puerto Rico, Jamaica, Cayman Islands), and Australia/New Zealand. The document bears a 'HOUSE_OVERSIGHT_024734' Bates stamp, indicating it was part of a document production to the House Oversight Committee, potentially related to investigations involving financial dealings or investments connected to the Epstein case, though no specific individuals are named on this page.
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein event